vancomycin-resistant enterococci

Also found in: Dictionary.
Related to vancomycin-resistant enterococci: VRE

vancomycin-resistant enterococci

Abbreviation: VRE
A strain of Enterococcus faecium resistant to antibiotics, including penicillins, aminoglycosides, and vancomycin. Infection with VRE presents a major threat to infected patients; although it can be treated with linezolid, its antibiotic resistance can be transferred to other gram-positive organisms, such as Staphylococcus aureus, making these bacteria also more difficult to eradicate.

To prevent the spread of VRE, the organism is identified by culture and sensitivity testing as soon as the infection is recognized. Contact precautions and cohorting of infected patients are used to control nosocomial spread. All persons entering the patient's room don gloves; hands are washed carefully both before they are donned and after they are removed. Gloves are removed just before leaving the room. Charts and flow sheets should not be taken into the room. Hospitals should heed the guidelines that have been developed for the use of vancomycin, to minimize the spread of vancomycin resistance to other organisms.

antibiotic resistance; multidrug resistance;
See also: Enterococcus
References in periodicals archive ?
Shortly after the first isolates of vancomycin-resistant enterococci (VRE) were reported by investigators in the United Kingdom and France, similar strains were detected in hospitals located in the eastern half of the United States.
Monday, April 02, 2012, Poster Session IV, 12:30 - 13:30, Spot P1659 A CE-marked automated molecular test on the Abbott m2000 for the detection of vancomycin resistance genes vanA and vanB most commonly found in vancomycin-resistant enterococci H.
MRX-I is a next-generation oral oxazolidinone antibiotic for treating methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) infections.
Involving ornithologists in the surveillance of vancomycin-resistant enterococci.
Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.
Recent publicity about the Vancomycin-resistant Enterococci (VRE) cases that have been detected at Auckland District Health Board hospitals have caused some national discussion and concern in the New Zealand media.
NICE, FRANCE -- Much like their American counterparts, European clinicians are now struggling with vancomycin-resistant Enterococci.
Ten xanthones with one or two isoprenoid groups and a prenylated benzophenone isolated from roots of Cudrania cochinchinensis (Moraceae) were tested for their antimicrobial activities against vancomycin-resistant enterococci (VRE).
difficile), and vancomycin-resistant enterococci are the most common antimicrobial-resistant pathogens.
More than 10 percent of the infections acquired by patients in hospitals now result from vancomycin-resistant enterococci.
But then we were faced with vancomycin-resistant enterococci in hospitals.

Full browser ?